ω-3 carboxylic acids for hypertriglyceridemia.

about

Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism.Omega-3-carboxylic acids provide efficacious anti-inflammatory activity in models of crystal-mediated inflammation.

P2860

Q38839105-64DF9C0C-C045-4F40-AFAE-D61DA0562709 Q49910318-A9599734-B7C4-4F01-A78F-2F2A7942F242

P2860

ω-3 carboxylic acids for hypertriglyceridemia.

Item

http://www.wikidata.org/entity/Q38283976

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

ω-3 carboxylic acids for hypertriglyceridemia.

@en

type

Item

label

ω-3 carboxylic acids for hypertriglyceridemia.

@en

prefLabel

ω-3 carboxylic acids for hypertriglyceridemia.

@en

P1476

ω-3 carboxylic acids for hypertriglyceridemia.

@en

P2093

Eli M Roth

http://www.w3.org/2001/XMLSchema#string

P2860

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

Effects of combination lipid therapy in type 2 diabetes mellitus.

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

P304

123-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.991307

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25480558

http://www.w3.org/2001/XMLSchema#string

ω-3 carboxylic acids for hypertriglyceridemia.

about

P2860

P2860

ω-3 carboxylic acids for hypertriglyceridemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698